These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. New oral anticoagulants: will they replace warfarin? Little JW Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 May; 113(5):575-80. PubMed ID: 22668618 [TBL] [Abstract][Full Text] [Related]
27. Direct oral anticoagulants in atrial fibrillation. Noll G; Noll S; Hürlimann D Semin Hematol; 2014 Apr; 51(2):139-46. PubMed ID: 24861798 [TBL] [Abstract][Full Text] [Related]
28. Pharmacology and safety of new oral anticoagulants: the challenge of bleeding persists. Levy JH Clin Lab Med; 2014 Sep; 34(3):443-52. PubMed ID: 25168936 [TBL] [Abstract][Full Text] [Related]
29. [New oral anticoagulants - sunset for warfarin in therapy of atrial fibrillation]. Koziński M; Obońska K; Kubica A; Navarese EP; Kubica J Kardiol Pol; 2012; 70(10):1053-60. PubMed ID: 23080100 [No Abstract] [Full Text] [Related]
30. A new era of oral anticoagulation in atrial fibrillation: implications in clinical practice. Kasmeridis C; Lip GY; Apostolakis S Hosp Pract (1995); 2013 Feb; 41(1):61-70. PubMed ID: 23466968 [TBL] [Abstract][Full Text] [Related]
31. Novel oral anticoagulants--key messages for the angiologist. Haas S; Spannagl M; Schellong SM Vasa; 2012 May; 41(3):177-91. PubMed ID: 22565619 [TBL] [Abstract][Full Text] [Related]
32. [The new Anticoagulants - Relevant Facts for the GP]. Asmis LM Praxis (Bern 1994); 2011 Aug; 100(16):971-6. PubMed ID: 21833915 [TBL] [Abstract][Full Text] [Related]
33. New oral anticoagulant agents - general features and outcomes in subsets of patients. Schulman S Thromb Haemost; 2014 Apr; 111(4):575-82. PubMed ID: 24452881 [TBL] [Abstract][Full Text] [Related]
34. Novel oral anticoagulants: a review of the literature and considerations in special clinical situations. Akwaa F; Spyropoulos AC Hosp Pract (1995); 2013 Feb; 41(1):8-18. PubMed ID: 23466963 [TBL] [Abstract][Full Text] [Related]
35. [Pharmacokinetics and pharmacodynamics of the new oral anticoagulants dabigatran and rivaroxaban]. Ordovás Baines JP; Climent Grana E; Jover Botella A; Valero García I Farm Hosp; 2009; 33(3):125-33. PubMed ID: 19712596 [TBL] [Abstract][Full Text] [Related]
36. What did we learn from new oral anticoagulant treatment? Esmon CT Thromb Res; 2012 Oct; 130 Suppl 1(Suppl 1):S41-3. PubMed ID: 23026659 [TBL] [Abstract][Full Text] [Related]
37. Cardiology patient page. Patient guide for taking the non-vitamin K antagonist oral anticoagulants for atrial fibrillation. Lane DA; Wood K Circulation; 2015 Apr; 131(16):e412-5. PubMed ID: 25901074 [No Abstract] [Full Text] [Related]
38. [From heparin to apixaban: anticoagulants cut both ways?]. Hartung K; Meyer F; Bock F; Isermann B Zentralbl Chir; 2014 Feb; 139(1):89-97. PubMed ID: 23460104 [TBL] [Abstract][Full Text] [Related]
39. Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation. Lip GY; Larsen TB; Skjøth F; Rasmussen LH J Am Coll Cardiol; 2012 Aug; 60(8):738-46. PubMed ID: 22575324 [TBL] [Abstract][Full Text] [Related]
40. Safety of novel oral anticoagulants compared with uninterrupted warfarin for catheter ablation of atrial fibrillation. Armbruster HL; Lindsley JP; Moranville MP; Habibi M; Khurram IM; Spragg DD; Berger RD; Calkins H; Marine JE Ann Pharmacother; 2015 Mar; 49(3):278-84. PubMed ID: 25515868 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]